Shandong Jincheng Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 105.8% in First Three Quarters of 2022

Shandong Jincheng Pharmaceutical Group Co.,Ltd. (山东金城医药集团股份有限公司) (300233.SZ) reported a net profit of 267.1 million yuan in the first three quarters of 2022, up 105.8% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 23.7% year-on-year.

At the end of the reporting period, it had 5.7 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 35.6%.